在HiCommunication之后的语音和神经成像效应:帕金森病随机对照组干预试验
Hanna Steurer1,2, Franziska Albrecht3,4, Joakim Körner Gustafsson1
1Department of Clinical Science, Intervention and Technology, Division of Speech and Language Pathology, Karolinska Institutet, 141 86 Huddinge, Stockholm, Sweden.
Brain communications
|July 25, 2024
概括
在帕金森病患者中,HiCommunication干预改善了语音声音水平和质量. 虽然效果在六个月后没有持续,但这项研究表明基于神经可塑性的语音疗法的潜力.
科学领域:
- 神经科学是一个神经科学.
- 语音语言病理学 语言病理学
- 神经学 神经学
背景情况:
- 帕金森病通常会导致语言和沟通障碍.
- 现有的干预措施往往缺乏对神经可塑性原则的关注.
- 需要新的小组干预措施来解决沟通缺陷.
研究的目的:
- 为了评估HiCommunication干预在帕金森病中的言语和沟通的有效性.
- 调查声音声学测量和大脑有效连接的变化.
- 探索神经可塑性在语音康复中的作用.
主要方法:
- 随机对照试验,95名帕金森病参与者.
- 干预组接受了HiCommunication;对照组接受了积极干预.
- 在干预前和后使用了声学分析 (语音声音水平,质量) 和静止状态fMRI与动态因果建模.
主要成果:
- 干预后,语音音量和语音质量 (声学语音质量指数,声波与噪声比率) 的显著改善.
- 在59%的参与者中观察到临床相关的语音声音水平增加.
- 改变了语音运动网络区域的有效大脑连接,包括补充运动区域.
结论:
- 在帕金森病中,HiCommunication显示出改善语音和沟通的前景.
- 干预诱导的神经可塑性可能是观察到的语言改善的基础.
- 需要对实施和持续影响进行进一步的研究.
相关概念视频
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
512
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
512


